Welcome to our dedicated page for NATIONAL HEALTHCARE SEC filings (Ticker: NHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NATIONAL HEALTHCARE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NATIONAL HEALTHCARE's regulatory disclosures and financial reporting.
National Healthcare Corp CEO Stephen Fowler Flatt exercised stock options to acquire 1,853 shares of common stock at an exercise price of $53.94 per share. These options were originally granted on March 8, 2023 under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d).
Following the transaction, Flatt directly holds 65,505 shares of common stock. He also retains stock options covering 10,000 shares at $94.10, 13,000 shares at $90.62, and 20,000 shares at $157.13, with expiration dates between 2029 and 2031.
National HealthCare Corp SVP and CFO Brian F. Kidd exercised stock options for 1,853 shares of common stock at an exercise price of $53.94 per share. The options were originally granted under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d).
Following the transaction, Kidd directly holds 29,130 shares of common stock. He also continues to hold options over 8,000 shares at an exercise price of $94.10, 9,500 shares at $90.62, and 14,000 shares at $157.13, with expirations between 2029 and 2031.
National Healthcare Corp Schedule 13G/A amendment reports Morgan Stanley entities as passive holders of Common Stock (CUSIP 635906100). The filing lists 1,102,537 shares beneficially owned by Morgan Stanley reporting units, representing 7.1% of the class, and 1,038,787 shares beneficially owned by Morgan Stanley Institutional Investment Advisors LLC, representing 6.7%.
The filing provides corporate addresses for the filers, cites Release No. 34-39538 for reporting-unit aggregation, and is signed by authorized signatories with dates of 03/12/2026. Exhibit references include a joint filing agreement and Item 7 subsidiary information.
National Healthcare Corp director James Paul Abernathy exercised stock options and increased his direct shareholdings. He exercised options covering 3,140 shares of common stock at an exercise price of $55.75 per share, receiving 3,140 common shares. Following the transaction, he directly owns 43,302 common shares.
The exercised options were part of a 2023 grant under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d). Abernathy still holds two additional option grants, each linked to 7,500 underlying common shares, with exercise prices of $96.03 and $94.66 per share and expirations in 2029 and 2030.
NATIONAL HEALTHCARE CORP Sr. VP of Patient Services Vicki L. Dodson reported option-related transactions in company stock. On March 4, 2026, she exercised 4,500 stock options granted under the 2020 Omnibus Equity Incentive Plan, receiving 4,500 common shares at an exercise price of $0.00 per share and a corresponding entry at $90.62 per share for the acquired stock.
In a separate transaction coded "F," 3,159 shares of common stock were withheld by the company to cover the exercise price and tax-withholding obligations, rather than sold on the open market. Following these transactions, she beneficially owns 12,712.5455 shares of NATIONAL HEALTHCARE CORP common stock directly, and continues to hold multiple option awards with remaining exercisable balances.
National HealthCare Corp senior VP & CIO Ben Anderson Sr reported option exercises and related share withholdings. On March 4, 2026 he exercised multiple “Option to Purchase Common Stock” grants under the 2020 Omnibus Equity Incentive Plan into common shares. The company then withheld a portion of common stock to cover the exercise price and tax obligations, as noted in the footnotes. Following these transactions, he beneficially owned a total of 19,550.0547 shares of National HealthCare Corp common stock.
NATIONAL HEALTHCARE CORP Senior VP & General Counsel Josh A. McCreary reported option-related transactions in company stock. On March 4, 2026, he exercised options for 4,500 shares of common stock at an exercise price of $90.62 per share.
To cover the exercise price and related tax withholding obligations, 3,202 shares of common stock were withheld by the company, classified as a tax-withholding disposition rather than an open-market sale. Following these transactions, McCreary directly beneficially owned 12,698 shares of NATIONAL HEALTHCARE CORP common stock.
National Healthcare Corp senior executive exercises stock options and settles taxes in shares
Timothy J. Shelly, Sr. VP Operations of National Healthcare Corp, exercised options to purchase 2,667 and 3,667 shares of common stock on March 4, 2026. These options were granted under the 2020 Omnibus Equity Incentive Plan, as noted in the footnotes.
In connection with these exercises, 4,481 shares of common stock were withheld by the company to pay the option exercise price and related tax obligations. After these transactions, Shelly held 3,147 shares of common stock directly, along with 2,400 and 14,000 options to purchase common stock.
National Healthcare Corp (NHC) senior vice president and CFO Brian F. Kidd reported option exercises and related share withholdings in company stock. On March 4, 2026, he exercised options for 2,000 shares of common stock at $53.94 per share and 4,000 shares at $90.62 per share under the 2020 Omnibus Equity Incentive Plan. The filing shows a tax-related disposition of 3,947 shares of common stock at $172.83 per share, with shares withheld by the company to pay the exercise price and withholding taxes. Following these transactions, Kidd beneficially owned 27,277 shares of common stock and held options to purchase 8,000 and 14,000 shares, all as direct ownership.
NATIONAL HEALTHCARE CORP director David R. Gifford filed an initial statement of beneficial ownership on Form 3. The filing identifies him as a director of the company and, based on the structured data, shows no reported insider purchase, sale, acquisition, or disposition transactions at this time.